Icon Advisers Inc Regeneron Pharmaceuticals, Inc. Transaction History

Icon Advisers Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 02, 2021	SELL	$478.3 - $607.98 $2.1 Million - $2.68 Million	-4,400 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$493.32 - $643.92 $690,648 - $901,488	1,400 Added 46.67%	4,400 $2.74 Million
Q3 2017 Nov 08, 2017	BUY	$431.38 - $504.0 $1.29 Million - $1.51 Million	3,000	3,000 $1.34 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Icon Advisers Inc, based on Form 13F filings with the SEC.

Stay updated on Icon Advisers Inc with notifications on news.